Engineered IL-10 variants elicit potent immuno-modulatory activities at therapeutic low ligand doses

Autor(en): Gorby, Claire
J, Sotolongo Bellón
Wilmes, S.
Warda, Walid
Pohler, Elizabeth
Fyfe, Paul K.
Cozzani, Adeline
Ferrand, Christophe
Walter, M. Todd
Mitra, S.
Piehler, Jacob 
Moraga, Ignacio
Stichwörter: Immunology; Monocyte; Receptor; CD8; T cell; Cytokine; Cell biology; Biology; Biochemistry; Ligand (biochemistry); Immune system
Erscheinungsdatum: 2020
DOI: https://doi.org/10.1101/2020.03.10.985069

Show full item record

Page view(s)

6
Last Week
0
Last month
0
checked on May 15, 2024

Google ScholarTM

Check

Altmetric